The human genome contains around 3 billion base pairs and 20,000-25,000 genes. Genes code for proteins and can vary in length from 1,000 to over 1.5 million base pairs. While genes make up about 1-1.4% of the genome, the remaining non-coding regions also play important regulatory roles. Genetic variations, from single mutations to complex interactions between multiple genes and the environment, underlie many diseases. New sequencing technologies are helping researchers better understand these relationships and develop personalized prevention and treatment approaches.
Human Genome Project (HGP) was an international scientific research project with the goal of determining the base pairs that make up human DNA, and of identifying and mapping all of the genes of the human genome from both a physical and a functional
Human Genome Project (HGP) was an international scientific research project with the goal of determining the base pairs that make up human DNA, and of identifying and mapping all of the genes of the human genome from both a physical and a functional
Comparative genomics in eukaryotes, organellesKAUSHAL SAHU
WHAT IS COMPARATIVE GENOMICS?
HISTORY
SOME RELATED TERMS
MINIMAL EUKARYOTIC GENOMES
COMPARISON OF THE MAJOR SEQUENCED GENOMES
EUKARYOTIC GENOMES
SACCHAROMYCES CEREVISIAE GENOME
INSECT GENOME
DROSOPHILA MELANOGASTER (FRUIT FLY) GENOME
COMPARATIVE ANALYSIS OF THE HUMAN AND MOUSE GENOME
COMPARATIVE GENOMICS OF ORGANELLES
COMPARATIVE GENOMICS TOOLS
CONCLUSION
REFERENCES
Genomic sequencing a sub-disciplinary branch of genetics and difference between the two sequencers used to sequence the genome basically automated sequencer and fluorescence sequencers and its applications.
A crisp and precise presentaion on Human genome project which will help you in your studies.
For original ppt file, contact me at :
Instagram: _s_a_k_s_h_a_m_
Twitter: @_SakshamAgrawal
or mail me at saksham.agrawal512@gmail.com
this is done by me and my team mates of Wayamba University Sri Lanka for our project.From now we decided to allow download this file.I would be greatful if you could send your comments..
And I'm willing to help you in similar works.I'm in final year of my degree(.BSc Biotechnology)..
pubudu_gokarella@yahoo.com
N-terminal tails of histones are the most accessible regions for modifications. These post-translational modification (PTM) of histones is a crucial step in epigenetic regulation of a gene.
Feature story from the Garvan Institute of Medical Research's April 2013 issue of Breakthrough newsletter. More at https://www.garvan.org.au/news-events/newsletters
The distinctive character of modern biology is the study of biology as information. Merging of biology and information sciences is a fundamental drive in biomedicine. Indeed, the post-genomic era is providing a huge of amount of molecular data, pertaining to different levels of evidence, which requires specific expertise in raw data processing, explorative data analysis and systems biology.
Translational genomics relies on our ability to recognize the functional elements of the genome and to disentangle the complexity of their interactions, starting from the sequence and following its implications in transcriptomics, proteomics, metabolomics, epigenomics. The promise of genomic medicine is improved diagnosis and treatment through the application of genomic information and technologies, leading to precision medicine.
This talk will give an overview of computational genomics and its current challenges.
Comparative genomics in eukaryotes, organellesKAUSHAL SAHU
WHAT IS COMPARATIVE GENOMICS?
HISTORY
SOME RELATED TERMS
MINIMAL EUKARYOTIC GENOMES
COMPARISON OF THE MAJOR SEQUENCED GENOMES
EUKARYOTIC GENOMES
SACCHAROMYCES CEREVISIAE GENOME
INSECT GENOME
DROSOPHILA MELANOGASTER (FRUIT FLY) GENOME
COMPARATIVE ANALYSIS OF THE HUMAN AND MOUSE GENOME
COMPARATIVE GENOMICS OF ORGANELLES
COMPARATIVE GENOMICS TOOLS
CONCLUSION
REFERENCES
Genomic sequencing a sub-disciplinary branch of genetics and difference between the two sequencers used to sequence the genome basically automated sequencer and fluorescence sequencers and its applications.
A crisp and precise presentaion on Human genome project which will help you in your studies.
For original ppt file, contact me at :
Instagram: _s_a_k_s_h_a_m_
Twitter: @_SakshamAgrawal
or mail me at saksham.agrawal512@gmail.com
this is done by me and my team mates of Wayamba University Sri Lanka for our project.From now we decided to allow download this file.I would be greatful if you could send your comments..
And I'm willing to help you in similar works.I'm in final year of my degree(.BSc Biotechnology)..
pubudu_gokarella@yahoo.com
N-terminal tails of histones are the most accessible regions for modifications. These post-translational modification (PTM) of histones is a crucial step in epigenetic regulation of a gene.
Feature story from the Garvan Institute of Medical Research's April 2013 issue of Breakthrough newsletter. More at https://www.garvan.org.au/news-events/newsletters
The distinctive character of modern biology is the study of biology as information. Merging of biology and information sciences is a fundamental drive in biomedicine. Indeed, the post-genomic era is providing a huge of amount of molecular data, pertaining to different levels of evidence, which requires specific expertise in raw data processing, explorative data analysis and systems biology.
Translational genomics relies on our ability to recognize the functional elements of the genome and to disentangle the complexity of their interactions, starting from the sequence and following its implications in transcriptomics, proteomics, metabolomics, epigenomics. The promise of genomic medicine is improved diagnosis and treatment through the application of genomic information and technologies, leading to precision medicine.
This talk will give an overview of computational genomics and its current challenges.
Discover the cutting-edge Gene Silencing approach in cardiovascular disease. Explore RNAi, ASOs, and their therapeutic applications for a healthier heart.
This presentation was given to me during my higher education in the Lebanese University, Faculty of Education. It includes detailed explanation about DNA microarray.
The DNA is the basis of our genetic code, we could almost say that we are all made of DNA; therefore all studies are trying to understand this important part of us. Over time, they have discovered that DNA contains all the instructions that control the development and function of every cell in our body. What we know is that the DNA is able to divide itself, replicating and giving two daughter strands which contain exactly the same information from DNA mother. Then these are transcribed into RNA and finally translated into proteins, this is what we know as the central dogma of genetic information.
Although nature seems to be so perfect there are some cases where this beautiful process fails, and this is where certain diseases are originated and can cause multiple problems. Scientists are increasingly closer to find answers and perhaps their studies can help in the future.
New treatments for Alzheimer's, autism and depression, could be developed.
It could be the starting point for future researches on genes involved in these diseases.
Knowing which genes are involved, people who are not sick yet, might prevent some disease.
These findings help us understand how diseases work and where they come from.
Encourages doctors and scientists to find more about this genes, to achieve excellent results that could benefit many people.
It gives us hope and determination to achieve incredible things in this medicine area; we know that humans are able to find and develop things that we have never imagine.
We know that DNA is the basis of everything, thus if we understand certain parts of it and what is involved on it, we would be able to control many diseases that affects society nowadays.
With these discovery we would be contributing to industry and researches.
new hypothesis could change the way we see things, and would make researchers focused in other cell structures such as ribosomes.
The cause of some diseases might not be in the DNA, but on the malfunctioning of ribosomes, in that way we must look for the real cause of them.
In my opinion this is a big step for medicine, although there is not yet a certain result, and they have to investigate more about the genes, they have a great part of the investigation that can guide them to find the solution to multiple diseases. I think that this kind of researches benefit a lot our society, because they are trying to improve people’s life, by finding the different places of de brain where illnesses are originated. With this project we can start thinking on possible cures and treatments for Alzheimer's, autism, depression and other disorders.
It's good to start investigating on other cellular structures that may be quite involved in the most complex processes of DNA. Scientists may have never wondered what real role of ribosome is. Thinking about new hypotheses and that maybe the ribosome is the central point is crazy but good, because they could be right.
Describe in your own words the benefits, but also the problems of ha.pdfarenamobiles123
Describe in your own words the benefits, but also the problems of having the human genome
deciphered. Write several paragraphs.
Solution
The history of the human race has been filled with curiosity and discovery about our abilities and
limitations. As an egotistical creature with a seemingly unstoppable desire for new
accomplishments, we attempt feats with emotion and tenacity. People worldwide raced to be the
first to discover the secrets and the ability of flight. Enormous amounts of monies were spent on
sending people into space and the race to land on the moon. With the rapid growth of scientific
knowledge and experimental methods, humans have begun to unravel and challenge another
mystery, the discovery of the entire genetic make-up of the human body.
This endeavor, the Human Genome Project (HGP), has created hopes and expectations about
better health care. It has also brought forth serious social issues. To understand the potential
positive and negative issues, we must first understand the history and technical aspects of the
HGP.
History of the Human Genome Project
The HGP has an ultimate goal of identifying and locating the positions of all genes in the human
body. A researcher named Renato Dulbecco first suggested the idea of such a project while the
U.S. Department of Energy (DOE) was also considering the same project because issues related
to radiation and chemical exposure were being raised. Military and civilian populations were
being exposed to radiation and possible carcinogenic chemicals through atomic testing, the use
of Agent Orange in Vietnam, and possible nuclear power facility accidents. Genetic knowledge
was needed to determine the resiliency of the human genome.
Worldwide discussion about a HGP began in 1985. In 1986, the DOE announced its\' Human
Genome Initiative which emphasized the development of resources and technologies for genome
mapping, sequencing, computation, and infrastructure support that would lead to the entire
human genome map. United States involvement began in October 1990 and was coordinated by
the DOE and the National Institute of Health (NIH). With an estimated cost of 3 billion dollars,
sources of funding also include the National Science Foundation (NSF) and the Howard Hughes
Medical Institute (HHMI). Because of the involvement of the NIH, DOE, and NSF who receive
U.S. Congressional funding, the HGP is partly funded through federal tax dollars. Expected to
last 15 years, technological advancements have accelerated the expected date of completion to
the year 2003. This completion date would coincide with the 50th anniversary of Watson and
Crick\'s description of the structure of DNA molecule.
Human Genome Project Goals
The specific goals of the HGP are to::
Technical Aspects of the HGP
Mapping Strategies
To sequence the human genome, maps are needed. Physical maps are a series of overlapping
pieces of DNA isolated in bacteria. Physical maps are used to describe the DNA\'s chemical
characteristics..
Open Source Pharma /Genomics and clinical practice / Prof Hosur opensourcepharmafound
Access to Research
Date 11-08-2018
Venue Conference HAll NIAS IISc campus
Conference and workshops for clinical practitioners to introduce them to modern tools and an alternative approach to modern scientific research.
Purpose
1. Build a network of physicians across the country
2 Train physicians to analyse clinical data and restructure it to make it compatible with research standards
3. Introduce modern tools to understand the mechanism of actions of medicine
4. Introduce artificial intelligence and machine learning to clinical practitioners to support decision-making processes
Access to Science
Clinical experience and traditional knowledge are important sources of data that affect decision making processes in modern healthcare systems. This data should be made accessible for scientific evaluation and validation to improve healthcare worldwide. The Open Source Pharma Foundation believes that clinical practitioners from various disciplines should have the right to access research so that they can help identify problems, contribute their scientific knowledge, and support the discovery ecosystem.
Background
The majority of medical practitioners working on the ground level with patients do not take part in open clinical research worldwide. However, the data collected and owned by them plays an important role in establishing better discovery pathways. Through this workshop, we seek to open opportunities to enhance health care systems around the world and to overcome the following challenges faced by medical practitioners.
1. Regulatory limitations
2. Academic limitations
3. Time constraints
4. Lack of access to modern tools
5. Lack of access to research facilities
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Tobias Schneck
As AI technology is pushing into IT I was wondering myself, as an “infrastructure container kubernetes guy”, how get this fancy AI technology get managed from an infrastructure operational view? Is it possible to apply our lovely cloud native principals as well? What benefit’s both technologies could bring to each other?
Let me take this questions and provide you a short journey through existing deployment models and use cases for AI software. On practical examples, we discuss what cloud/on-premise strategy we may need for applying it to our own infrastructure to get it to work from an enterprise perspective. I want to give an overview about infrastructure requirements and technologies, what could be beneficial or limiting your AI use cases in an enterprise environment. An interactive Demo will give you some insides, what approaches I got already working for real.
State of ICS and IoT Cyber Threat Landscape Report 2024 previewPrayukth K V
The IoT and OT threat landscape report has been prepared by the Threat Research Team at Sectrio using data from Sectrio, cyber threat intelligence farming facilities spread across over 85 cities around the world. In addition, Sectrio also runs AI-based advanced threat and payload engagement facilities that serve as sinks to attract and engage sophisticated threat actors, and newer malware including new variants and latent threats that are at an earlier stage of development.
The latest edition of the OT/ICS and IoT security Threat Landscape Report 2024 also covers:
State of global ICS asset and network exposure
Sectoral targets and attacks as well as the cost of ransom
Global APT activity, AI usage, actor and tactic profiles, and implications
Rise in volumes of AI-powered cyberattacks
Major cyber events in 2024
Malware and malicious payload trends
Cyberattack types and targets
Vulnerability exploit attempts on CVEs
Attacks on counties – USA
Expansion of bot farms – how, where, and why
In-depth analysis of the cyber threat landscape across North America, South America, Europe, APAC, and the Middle East
Why are attacks on smart factories rising?
Cyber risk predictions
Axis of attacks – Europe
Systemic attacks in the Middle East
Download the full report from here:
https://sectrio.com/resources/ot-threat-landscape-reports/sectrio-releases-ot-ics-and-iot-security-threat-landscape-report-2024/
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...James Anderson
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
The Art of the Pitch: WordPress Relationships and SalesLaura Byrne
Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes?
All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Jeffrey Haguewood
Sidekick Solutions uses Bonterra Impact Management (fka Social Solutions Apricot) and automation solutions to integrate data for business workflows.
We believe integration and automation are essential to user experience and the promise of efficient work through technology. Automation is the critical ingredient to realizing that full vision. We develop integration products and services for Bonterra Case Management software to support the deployment of automations for a variety of use cases.
This video focuses on the notifications, alerts, and approval requests using Slack for Bonterra Impact Management. The solutions covered in this webinar can also be deployed for Microsoft Teams.
Interested in deploying notification automations for Bonterra Impact Management? Contact us at sales@sidekicksolutionsllc.com to discuss next steps.
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...DanBrown980551
Do you want to learn how to model and simulate an electrical network from scratch in under an hour?
Then welcome to this PowSyBl workshop, hosted by Rte, the French Transmission System Operator (TSO)!
During the webinar, you will discover the PowSyBl ecosystem as well as handle and study an electrical network through an interactive Python notebook.
PowSyBl is an open source project hosted by LF Energy, which offers a comprehensive set of features for electrical grid modelling and simulation. Among other advanced features, PowSyBl provides:
- A fully editable and extendable library for grid component modelling;
- Visualization tools to display your network;
- Grid simulation tools, such as power flows, security analyses (with or without remedial actions) and sensitivity analyses;
The framework is mostly written in Java, with a Python binding so that Python developers can access PowSyBl functionalities as well.
What you will learn during the webinar:
- For beginners: discover PowSyBl's functionalities through a quick general presentation and the notebook, without needing any expert coding skills;
- For advanced developers: master the skills to efficiently apply PowSyBl functionalities to your real-world scenarios.
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...UiPathCommunity
💥 Speed, accuracy, and scaling – discover the superpowers of GenAI in action with UiPath Document Understanding and Communications Mining™:
See how to accelerate model training and optimize model performance with active learning
Learn about the latest enhancements to out-of-the-box document processing – with little to no training required
Get an exclusive demo of the new family of UiPath LLMs – GenAI models specialized for processing different types of documents and messages
This is a hands-on session specifically designed for automation developers and AI enthusiasts seeking to enhance their knowledge in leveraging the latest intelligent document processing capabilities offered by UiPath.
Speakers:
👨🏫 Andras Palfi, Senior Product Manager, UiPath
👩🏫 Lenka Dulovicova, Product Program Manager, UiPath
Neuro-symbolic is not enough, we need neuro-*semantic*Frank van Harmelen
Neuro-symbolic (NeSy) AI is on the rise. However, simply machine learning on just any symbolic structure is not sufficient to really harvest the gains of NeSy. These will only be gained when the symbolic structures have an actual semantics. I give an operational definition of semantics as “predictable inference”.
All of this illustrated with link prediction over knowledge graphs, but the argument is general.
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf91mobiles
91mobiles recently conducted a Smart TV Buyer Insights Survey in which we asked over 3,000 respondents about the TV they own, aspects they look at on a new TV, and their TV buying preferences.
UiPath Test Automation using UiPath Test Suite series, part 4DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 4. In this session, we will cover Test Manager overview along with SAP heatmap.
The UiPath Test Manager overview with SAP heatmap webinar offers a concise yet comprehensive exploration of the role of a Test Manager within SAP environments, coupled with the utilization of heatmaps for effective testing strategies.
Participants will gain insights into the responsibilities, challenges, and best practices associated with test management in SAP projects. Additionally, the webinar delves into the significance of heatmaps as a visual aid for identifying testing priorities, areas of risk, and resource allocation within SAP landscapes. Through this session, attendees can expect to enhance their understanding of test management principles while learning practical approaches to optimize testing processes in SAP environments using heatmap visualization techniques
What will you get from this session?
1. Insights into SAP testing best practices
2. Heatmap utilization for testing
3. Optimization of testing processes
4. Demo
Topics covered:
Execution from the test manager
Orchestrator execution result
Defect reporting
SAP heatmap example with demo
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
7. Genes are Functional Units. That means that genes are not
microscopically visible, like the chromosomes or the chromatine.
Geneticists divided the DNA into groups of nucleotides that code for
one single protein. This is called a gene.
8. Genes can contain from 1,000 to more than 1.5 million nucleotides
(or base pairs) depending how large the protein they are coding for
are.
This protein is Titin. It consists of 27,000 amino acids.
9. The human genome project was completed in 2003.
It was established that human genome contains about 20,000 to
25,000 genes.
Journal Nature 2003
10. Only 1.1% to1.4% of the genome's sequences code for proteins.
Exons are coding regions, Introns are non-coding regions.
11. Non-coding regions are initially copied into RNA, but they are left
out of the final RNA version (reason unknown).
12. About 10% of the genes in the human genome encode for DNA binding
proteins(regulatory proteins).
Some of these proteins recognize and attach to specific bits of DNA to
activate gene expression (ex. transcription factors, polymerases, nucleases)
13. A genetic variation is a permanent change in the DNA sequence that
makes up a gene. Most variants are harmless or have no effects at
all.
However, other variations can have harmful effects leading to
disease.
14. Some genetic variations affect only a single gene.
Single gene mutations are responsible for many rare inherited
neurological diseases.
For example Huntington’s disease is a result of what is called an
expanded “triplet repeat” , a stutter in the huntingtin gene sequence.
15. In the huntingtin gene, triplet repeats of 20 to 30
times are normal and cause no symptoms.
In people with Huntington’s disease, the number of
repeats reaches 40 or more.
The mutation creates an abnormally shaped protein
that is toxic to neurons.
As cells start to die, the symptoms of Huntington’s
disease appear. They consist of uncontrollable
writhing movements of the legs and arms, a loss of
muscle coordination, and changes in personality
and thinking.
16. Some cases of Lewy body dementia have been linked to having two or more
copies of the SNCA gene.
This gene encodes a protein called alpha-synuclein.
The excess alpha-synuclein accumulates inside the brain cells, jamming the
cells’ machinery.
17. Some diseases show familial clustering but do
not conform to any recognized pattern of
single gene inheritance. They are termed
multifactorial or complex disorders.
Multifactorial or complex disorders depend
on many genes and the environment.
18. Geneticists search for connections between
genes and disease risk by performing three
kinds of studies:
Linkage Studies (using DNA or RNA)
Genome Wide Association Studies (using DNA)
Gene Expression Profiling (using RNA)
When a DNA or RNA portion is presumed to contain a
susceptibility locus for a disease, that area is red nucleotide
by nucleotide. This process is called DNA or RNA sequencing.
19. Regardless of which study is used, the end result is DNA or RNA sequencing. For this
purpose a device called a microarray, is employed. This is a small chip ( a gene chip),
coated with row upon row of DNA or RNA fragments.
20. Sequencing was once a time-
consuming and expensive
procedure, but a new set of
techniques called next-
generation sequencing has
emerged as an efficient, cost-
effective way to get a detailed
readout of the genome
For ex. the Lindsay's approach
has the potential to sequence
DNA at a speed of hundreds to
thousands of base pairs per
second.
21. In laboratory, GWA studies and gene expression profiling studies are
leading to insights into new possibilities for disease prevention,
diagnosis and treatment.
When geneticists identify a gene or gene regulatory pathway associated
with a disease, they uncover potential new targets for therapy.
Understanding the relationship between genes and complex diseases
also is expected to play a role in personalized medicine.
One day a microarray-based genome scanning could become a routine
way to estimate a person’s genetic risk of developing diseases like
stroke, Alzheimer’s disease, Parkinson’s disease and certain brain
cancers.
Also researchers hope to develop customized drug “cocktails” that are
matched to a person’s unique genetic profile. Researchers believe that
these customized drugs will be much less likely than current medicines
to cause side-effects.